According to Britannia Life Sciences latest financial reports the total debt is $4.68M, an increase of 2406.35% to 2022. At the end of 2022 company had $186.77K total debt. This figure represents the debts and financial obligations that Britannia Life Sciences combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $4.68M | 2406.35% |
2022 | $186.77K | -90.05% |
2021 | $1.88M | - |